Idioma: Inglés
Publicado por Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Librería: WorldofBooks, Goring-By-Sea, WS, Reino Unido
EUR 3,34
Cantidad disponible: 2 disponibles
Añadir al carritoPaperback. Condición: Fine.
Idioma: Inglés
Publicado por Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Librería: Open Books, Chicago, IL, Estados Unidos de America
EUR 20,47
Cantidad disponible: 1 disponibles
Añadir al carritohardcover. Condición: Very Good. Open Books is a nonprofit social venture that provides literacy experiences for thousands of readers each year through inspiring programs and creative capitalization of books.
Idioma: Inglés
Publicado por Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Librería: Books From California, Simi Valley, CA, Estados Unidos de America
EUR 21,15
Cantidad disponible: 1 disponibles
Añadir al carritohardcover. Condición: Good. Cover and edges may have some wear.
Idioma: Inglés
Publicado por Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Librería: Books From California, Simi Valley, CA, Estados Unidos de America
EUR 21,15
Cantidad disponible: 1 disponibles
Añadir al carritohardcover. Condición: Very Good. Cover and edges may have some wear. Mild to Moderate creasing / bending to covers and pages.
Idioma: Inglés
Publicado por Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Librería: Zebra Books, Cambridge, Reino Unido
EUR 23,87
Cantidad disponible: 1 disponibles
Añadir al carritohardcover. Condición: Very Good. Remainder with a "damaged" stamp to copyright page - upper board corners slightly bumped - minimal surface wear - very good condition.
Idioma: Inglés
Publicado por Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Librería: Prior Books Ltd, Cheltenham, Reino Unido
EUR 29,84
Cantidad disponible: 1 disponibles
Añadir al carritohardcover. Condición: Like New. A firm and square hardback with sharp corners and strong joints just showing a few very minor rubs. Hence a non-text page has a small 'damaged' stamp. Despite such this book is actually in nearly new condition and appears unread. Thus the contents are crisp, fresh and tight. Also, no pen-marks and not from a library so no such stamps or labels. Now offered for sale at a very sensible price.
Idioma: Inglés
Publicado por Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 142,21
Cantidad disponible: 2 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Librería: California Books, Miami, FL, Estados Unidos de America
EUR 145,93
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 132,77
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Idioma: Inglés
Publicado por Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 132,76
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 149,33
Cantidad disponible: 2 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Idioma: Inglés
Publicado por Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Librería: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
EUR 153,96
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 154,04
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Idioma: Inglés
Publicado por Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 196,28
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. New edition NO-PA16APR2015-KAP.
Idioma: Inglés
Publicado por Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Librería: Kennys Bookstore, Olney, MD, Estados Unidos de America
EUR 193,80
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Librería: Revaluation Books, Exeter, Reino Unido
EUR 199,69
Cantidad disponible: 2 disponibles
Añadir al carritoHardcover. Condición: Brand New. 1st edition. 554 pages. 10.00x7.25x1.25 inches. In Stock.
Idioma: Inglés
Publicado por Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 236,63
Cantidad disponible: 1 disponibles
Añadir al carritoBuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - Alzheimer's Disease (AD) is a growing global public health challenge. The development of new therapies is urgently needed, and a complex ecosystem of organizations has grown to facilitate AD drug discovery and development. Masterfully collating information on the drug development ecosystem, this book emphasizes the contributions of each aspect in the pipeline with a uniform approach to chapters, enabling readers to access relevant information quickly. Topics covered include the use of non-clinical laboratory studies, biomarker development, artificial intelligence, design and management of clinical trials, and funding and financing models. Also discussed is the critical role of advocacy fundraising for drug development. With the approval of aducanumab, the function of the ecosystem has become apparent. This is a definitive overview of how the ecosystem works in transferring an AD drug from its discovery in the laboratory through clinical trial testing to regulatory review and eventual marketing.
Idioma: Inglés
Publicado por Cambridge University Press, Cambridge, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de America
EUR 144,57
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: new. Hardcover. Alzheimer's Disease (AD) is a growing global public health challenge. The development of new therapies is urgently needed, and a complex ecosystem of organizations has grown to facilitate AD drug discovery and development. Masterfully collating information on the drug development ecosystem, this book emphasizes the contributions of each aspect in the pipeline with a uniform approach to chapters, enabling readers to access relevant information quickly. Topics covered include the use of non-clinical laboratory studies, biomarker development, artificial intelligence, design and management of clinical trials, and funding and financing models. Also discussed is the critical role of advocacy fundraising for drug development. With the approval of aducanumab, the function of the ecosystem has become apparent. This is a definitive overview of how the ecosystem works in transferring an AD drug from its discovery in the laboratory through clinical trial testing to regulatory review and eventual marketing. Provides a definitive overview of the complex ecosystem facilitating Alzheimer's Disease drug research and development. Demonstrates a drug's journey from in the lab, clinical trial testing, regulatory review, and marketing by pharmaceutical companies. Details the use of artificial intelligence, clinical trial management, and financing models. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Librería: Revaluation Books, Exeter, Reino Unido
EUR 136,19
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: Brand New. 1st edition. 554 pages. 10.00x7.25x1.25 inches. In Stock. This item is printed on demand.
Idioma: Inglés
Publicado por Cambridge University Press, Cambridge, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Librería: CitiRetail, Stevenage, Reino Unido
EUR 149,20
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: new. Hardcover. Alzheimer's Disease (AD) is a growing global public health challenge. The development of new therapies is urgently needed, and a complex ecosystem of organizations has grown to facilitate AD drug discovery and development. Masterfully collating information on the drug development ecosystem, this book emphasizes the contributions of each aspect in the pipeline with a uniform approach to chapters, enabling readers to access relevant information quickly. Topics covered include the use of non-clinical laboratory studies, biomarker development, artificial intelligence, design and management of clinical trials, and funding and financing models. Also discussed is the critical role of advocacy fundraising for drug development. With the approval of aducanumab, the function of the ecosystem has become apparent. This is a definitive overview of how the ecosystem works in transferring an AD drug from its discovery in the laboratory through clinical trial testing to regulatory review and eventual marketing. Provides a definitive overview of the complex ecosystem facilitating Alzheimer's Disease drug research and development. Demonstrates a drug's journey from in the lab, clinical trial testing, regulatory review, and marketing by pharmaceutical companies. Details the use of artificial intelligence, clinical trial management, and financing models. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Idioma: Inglés
Publicado por Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Librería: moluna, Greven, Alemania
EUR 144,48
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Provides a definitive overview of the complex ecosystem facilitating Alzheimer s Disease drug research and development. Demonstrates a drug s journey from in the lab, clinical trial testing, regulatory review, and marketing by pharmaceutical companies. Deta.
Idioma: Inglés
Publicado por Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Librería: Majestic Books, Hounslow, Reino Unido
EUR 198,18
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. Print on Demand.
Idioma: Inglés
Publicado por Cambridge University Press, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Librería: Biblios, Frankfurt am main, HESSE, Alemania
EUR 201,79
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. PRINT ON DEMAND.
Idioma: Inglés
Publicado por Cambridge University Press, Cambridge, 2022
ISBN 10: 1108838669 ISBN 13: 9781108838665
Librería: AussieBookSeller, Truganina, VIC, Australia
EUR 200,39
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: new. Hardcover. Alzheimer's Disease (AD) is a growing global public health challenge. The development of new therapies is urgently needed, and a complex ecosystem of organizations has grown to facilitate AD drug discovery and development. Masterfully collating information on the drug development ecosystem, this book emphasizes the contributions of each aspect in the pipeline with a uniform approach to chapters, enabling readers to access relevant information quickly. Topics covered include the use of non-clinical laboratory studies, biomarker development, artificial intelligence, design and management of clinical trials, and funding and financing models. Also discussed is the critical role of advocacy fundraising for drug development. With the approval of aducanumab, the function of the ecosystem has become apparent. This is a definitive overview of how the ecosystem works in transferring an AD drug from its discovery in the laboratory through clinical trial testing to regulatory review and eventual marketing. Provides a definitive overview of the complex ecosystem facilitating Alzheimer's Disease drug research and development. Demonstrates a drug's journey from in the lab, clinical trial testing, regulatory review, and marketing by pharmaceutical companies. Details the use of artificial intelligence, clinical trial management, and financing models. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.